blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2075249

EP2075249 - Indolylmaleimide derivatives [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.02.2013
Database last updated on 28.03.2026
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU		published on 19.08.2015  [2015/34]
Applicant(s)For:BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GB  GR  HU  IE  IT  LI  LU  MC  NL  PT  RO  SE  SI  SK  TR 
Novartis AG
Lichtstrasse 35
4056 Basel / CH
For:AT 
Novartis Pharma GmbH
Brunner Strasse 59
1230 Wien / AT
[2012/13]
Former [2009/27]For:BE  BG  CH  CY  CZ  DE  DK  EE  ES  FI  FR  GB  GR  HU  IE  IT  LI  LU  MC  NL  PT  RO  SE  SI  SK  TR 
NOVARTIS AG
Lichtstrasse 35
4056 Basel / CH
For:AT 
Novartis Pharma GmbH
Brunner Strasse 59
1230 Wien / AT
Inventor(s)01 / Von Matt, Peter
Fichtlirain 38
4105 Biel-Benken / CH
02 / Wagner, Jürgen
Nussbaumweg 24
4103 Bottmingen / CH
 [2009/27]
Representative(s)Maucher, Wolfgang, et al
Patent- und Rechtsanwaltssozietät
Maucher, Börjes & Kollegen
Urachstrasse 23
79102 Freiburg im Breisgau / DE
[N/P]
Former [2012/13]Maucher, Wolfgang, et al
Patent- und Rechtsanwaltssozietät Maucher, Börjes & Kollegen Urachstrasse 23
79102 Freiburg im Breisgau / DE
Former [2009/27]Maucher, Wolfgang, et al
Patent- und Rechtsanwaltssozietät Maucher, Börjes & Kollegen Urachstrasse 23
79102 Freiburg i. Br. / DE
Application number, filing date09004073.412.02.2004
[2009/27]
Priority number, dateGB2003000331913.02.2003         Original published format: GB 0303319
[2009/27]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2075249
Date:01.07.2009
Language:EN
[2009/27]
Type: A3 Search report 
No.:EP2075249
Date:02.09.2009
[2009/36]
Type: B1 Patent specification 
No.:EP2075249
Date:28.03.2012
Language:EN
[2012/13]
Search report(s)(Supplementary) European search report - dispatched on:EP04.08.2009
ClassificationIPC:C07D401/14, C07D403/14, A61K31/44, A61K31/40, A61P29/00
[2009/27]
CPC:
C07D401/14 (EP,US); A61P1/04 (EP); A61P1/18 (EP);
A61P11/00 (EP); A61P13/12 (EP); A61P17/02 (EP);
A61P17/06 (EP); A61P19/02 (EP); A61P21/04 (EP);
A61P25/00 (EP); A61P25/28 (EP); A61P27/02 (EP);
A61P29/00 (EP); A61P3/04 (EP); A61P3/10 (EP);
A61P31/18 (EP); A61P35/00 (EP); A61P37/00 (EP);
A61P37/02 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61P9/00 (EP); A61P9/04 (EP);
A61P9/10 (EP); A61P9/12 (EP); C07D403/14 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2009/27]
TitleGerman:Indolylmaleimid-Derivate[2009/27]
English:Indolylmaleimide derivatives[2009/27]
French:Dérivés d'indolylmaleimide[2009/27]
Examination procedure19.03.2009Examination requested  [2009/27]
30.10.2009Despatch of a communication from the examining division (Time limit: M04)
11.02.2010Reply to a communication from the examining division
22.09.2010Despatch of a communication from the examining division (Time limit: M04)
11.01.2011Reply to a communication from the examining division
31.10.2011Communication of intention to grant the patent
24.12.2011Fee for grant paid
24.12.2011Fee for publishing/printing paid
Parent application(s)   TooltipEP04710393.2  / EP1597250
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040710393) is  10.09.2007
Opposition(s)03.01.2013No opposition filed within time limit [2013/10]
Fees paidRenewal fee
19.03.2009Renewal fee patent year 03
19.03.2009Renewal fee patent year 04
19.03.2009Renewal fee patent year 05
19.03.2009Renewal fee patent year 06
16.02.2010Renewal fee patent year 07
15.02.2011Renewal fee patent year 08
15.02.2012Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU12.02.2004
AT28.03.2012
BE28.03.2012
CY28.03.2012
CZ28.03.2012
DK28.03.2012
EE28.03.2012
FI28.03.2012
NL28.03.2012
RO28.03.2012
SE28.03.2012
SI28.03.2012
SK28.03.2012
TR28.03.2012
BG28.06.2012
GR29.06.2012
PT30.07.2012
[2015/34]
Former [2015/32]AT28.03.2012
BE28.03.2012
CY28.03.2012
CZ28.03.2012
DK28.03.2012
EE28.03.2012
FI28.03.2012
NL28.03.2012
RO28.03.2012
SE28.03.2012
SI28.03.2012
SK28.03.2012
TR28.03.2012
BG28.06.2012
GR29.06.2012
PT30.07.2012
Former [2013/33]AT28.03.2012
BE28.03.2012
CY28.03.2012
CZ28.03.2012
DK28.03.2012
EE28.03.2012
FI28.03.2012
NL28.03.2012
RO28.03.2012
SE28.03.2012
SI28.03.2012
SK28.03.2012
BG28.06.2012
GR29.06.2012
PT30.07.2012
Former [2013/08]AT28.03.2012
BE28.03.2012
CY28.03.2012
CZ28.03.2012
DK28.03.2012
EE28.03.2012
FI28.03.2012
NL28.03.2012
RO28.03.2012
SE28.03.2012
SI28.03.2012
SK28.03.2012
GR29.06.2012
PT30.07.2012
Former [2013/07]AT28.03.2012
BE28.03.2012
CY28.03.2012
CZ28.03.2012
EE28.03.2012
FI28.03.2012
RO28.03.2012
SE28.03.2012
SI28.03.2012
SK28.03.2012
GR29.06.2012
PT30.07.2012
Former [2013/01]BE28.03.2012
CY28.03.2012
CZ28.03.2012
EE28.03.2012
FI28.03.2012
RO28.03.2012
SE28.03.2012
SI28.03.2012
SK28.03.2012
GR29.06.2012
PT30.07.2012
Former [2012/50]BE28.03.2012
CY28.03.2012
CZ28.03.2012
EE28.03.2012
FI28.03.2012
RO28.03.2012
SE28.03.2012
SI28.03.2012
SK28.03.2012
GR29.06.2012
Former [2012/49]BE28.03.2012
CY28.03.2012
CZ28.03.2012
EE28.03.2012
FI28.03.2012
RO28.03.2012
SE28.03.2012
SI28.03.2012
GR29.06.2012
Former [2012/48]BE28.03.2012
CY28.03.2012
EE28.03.2012
FI28.03.2012
SE28.03.2012
GR29.06.2012
Former [2012/46]BE28.03.2012
CY28.03.2012
FI28.03.2012
GR29.06.2012
Former [2012/41]CY28.03.2012
FI28.03.2012
GR29.06.2012
Former [2012/37]FI28.03.2012
GR29.06.2012
Former [2012/36]GR29.06.2012
Documents cited:Search[A] US5057614  (DAVIS PETER D et al.)
 [A] WO0238561  (NOVARTIS AG et al.)
 [AP] WO03076398  (LILLY CO ELI et al.)
by applicantWO0238561
 WO03008259
   D. GEIGES ET AL., BIOCHEM. PHARMACOL., vol. 53, 1997, pages 865 - 875
   J. IMMUNOL. METHODS, vol. 2, 1973, pages 279
   MEO T. ET AL.: "Immunological Methods", 1979, ACADEMIC PRESS, pages: 227 - 39
   Q. M. WANG ET AL., J. BIOL. CHEM., vol. 269, 1994, pages 14566 - 14574
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.